Login / Signup

Efficacy of immune-checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta-analysis.

Yulia KundelMichal SternschussAssaf MooreGali PerlBaruch BrennerHadar Goldvaser
Published in: Cancer medicine (2020)
Compared to standard treatment, ICIs in metastatic gastric/GEJ adenocarcinoma did not improve OS. None of the evaluated subgroups has shown increased magnitude of effect to ICIs, aside of the small group with MSI-H tumors.
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • locally advanced
  • case report
  • combination therapy
  • radiation therapy